Found: 49
Select item for more details and to access through your institution.
Biodistribution and tissue toxicity of amphotericin B in mice following multiple dose administration of a novel oral lipid-based formulation (iCo-009).
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 12, p. 2610, doi. 10.1093/jac/dkq358
- By:
- Publication type:
- Article
Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation.
- Published in:
- 2010
- By:
- Publication type:
- Correction Notice
Visceral leishmaniasis affects liver and spleen concentrations of amphotericin B following administration to mice.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 3, p. 535, doi. 10.1093/jac/dkp465
- By:
- Publication type:
- Article
Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 64, n. 1, p. 101, doi. 10.1093/jac/dkp140
- By:
- Publication type:
- Article
Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 1, p. 84, doi. 10.1038/nrd2353
- By:
- Publication type:
- Article
Review of Novel Oral Amphotericin B Formulations for the Treatment of Parasitic Infections.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 11, p. 2316, doi. 10.3390/pharmaceutics14112316
- By:
- Publication type:
- Article
Inhibition of Scavenger Receptor Class B Type 1 (SR-B1) Expression and Activity as a Potential Novel Target to Disrupt Cholesterol Availability in Castration-Resistant Prostate Cancer.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 9, p. 1509, doi. 10.3390/pharmaceutics13091509
- By:
- Publication type:
- Article
Extracellular Vesicles as Potential Theranostic Platforms for Skin Diseases and Aging.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 5, p. 760, doi. 10.3390/pharmaceutics13050760
- By:
- Publication type:
- Article
Polymeric Carriers Designed for Encapsulation of Essential Oils with Biological Activity.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 5, p. 631, doi. 10.3390/pharmaceutics13050631
- By:
- Publication type:
- Article
Convection Enhanced Delivery in the Setting of High-Grade Gliomas.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 4, p. 561, doi. 10.3390/pharmaceutics13040561
- By:
- Publication type:
- Article
Pharmacokinetic Disposition of Amiodarone When Given with an Intralipid Rescue Strategy.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 4, p. 539, doi. 10.3390/pharmaceutics13040539
- By:
- Publication type:
- Article
Pharmacokinetic Changes According to Single or Multiple Oral Administrations of Socheongryong-Tang to Rats: Presented as a Typical Example of Changes in the Pharmacokinetics Following Multiple Exposures to Herbal Medicines.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 4, p. 478, doi. 10.3390/pharmaceutics13040478
- By:
- Publication type:
- Article
Stability and Influence of Storage Conditions on Nanofibrous Film Containing Tooth Whitening Agent.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 4, p. 449, doi. 10.3390/pharmaceutics13040449
- By:
- Publication type:
- Article
Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-catenin Downregulation and AMPK Activation.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 3, p. 330, doi. 10.3390/pharmaceutics13030330
- By:
- Publication type:
- Article
Analytical Strategies to Analyze the Oxidation Products of Phytosterols, and Formulation-Based Approaches to Reduce Their Generation.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 2, p. 268, doi. 10.3390/pharmaceutics13020268
- By:
- Publication type:
- Article
Development and Characterization of Liposomal Formulations Containing Phytosterols Extracted from Canola Oil Deodorizer Distillate along with Tocopherols as Food Additives.
- Published in:
- Pharmaceutics, 2019, v. 11, n. 4, p. 185, doi. 10.3390/pharmaceutics11040185
- By:
- Publication type:
- Article
The Development of Oral Amphotericin B to Treat Systemic Fungal and Parasitic Infections: Has the Myth Been Finally Realized?
- Published in:
- Pharmaceutics, 2019, v. 11, n. 3, p. 99, doi. 10.3390/pharmaceutics11030099
- By:
- Publication type:
- Article
Pharmacokinetics and Drug Metabolism in Canada: The Current Landscape--A Summary of This Indispensable Special Issue.
- Published in:
- Pharmaceutics, 2018, v. 10, n. 1, p. 13, doi. 10.3390/pharmaceutics10010013
- By:
- Publication type:
- Article
An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery.
- Published in:
- Pharmaceutics, 2017, v. 9, n. 4, p. 53, doi. 10.3390/pharmaceutics9040053
- By:
- Publication type:
- Article
Canadian contributions to research on neglected tropical diseases.
- Published in:
- PLoS Neglected Tropical Diseases, 2021, v. 15, n. 6, p. 1, doi. 10.1371/journal.pntd.0009476
- By:
- Publication type:
- Article
Postnatal manipulation of Pax6 dosage reverses congenital tissue malformation defects.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 1, p. 111, doi. 10.1172/JCI70462
- By:
- Publication type:
- Article
Modification of Amphotericin B's Therapeutic Index by Increasing Its Association with Serum High-Density Lipoproteinsa.
- Published in:
- Annals of the New York Academy of Sciences, 1994, v. 730, n. 1, p. 93, doi. 10.1111/j.1749-6632.1994.tb44242.x
- By:
- Publication type:
- Article
Enhancement of the Treatment of Experimental Candidiasis with Vascular Decongestants.
- Published in:
- Journal of Infectious Diseases, 1990, v. 162, n. 1, p. 211
- By:
- Publication type:
- Article
Pharmacokinetics, Tissue Distribution, and Toxicity of Free and Liposomal Amphotericin B in Diabetic Rats.
- Published in:
- Journal of Infectious Diseases, 1990, v. 161, n. 3, p. 562
- By:
- Publication type:
- Article
Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment.
- Published in:
- Journal of Psychiatry & Neuroscience, 2007, v. 32, n. 5, p. 331
- By:
- Publication type:
- Article
Highly Effective Oral Amphotericin B Formulation against Murine Visceral Leishmaniasis.
- Published in:
- Journal of Infectious Diseases, 2009, v. 200, n. 3, p. 357, doi. 10.1086/600105
- By:
- Publication type:
- Article
Amphotericin B-loaded bone cement to treat osteomyelitis caused by Candida albicans.
- Published in:
- Canadian Journal of Surgery, 2001, v. 44, n. 5, p. 383
- By:
- Publication type:
- Article
A <sup>89</sup>Zr-labeled lipoplex nanosystem for image-guided gene delivery: design, evaluation of stability and in vivo behavior.
- Published in:
- International Journal of Nanomedicine, 2018, v. 13, p. 7801, doi. 10.2147/IJN.S179806
- By:
- Publication type:
- Article
Development and deployment of a solid oral amphotericin B dosage form to treat visceral leishmaniasis within a pediatric population.
- Published in:
- PLoS Neglected Tropical Diseases, 2024, v. 18, n. 9, p. 1, doi. 10.1371/journal.pntd.0012500
- By:
- Publication type:
- Article
Physician centric healthcare: is it time for a paradigm shift?
- Published in:
- 2017
- By:
- Publication type:
- journal article
The effect of two novel cholesterol-lowering agents, disodium ascorbyl phytostanol phosphate (DAPP) and nanostructured aluminosilicate (NSAS) on the expression and activity of P-glycoprotein within Caco-2 cells.
- Published in:
- Lipids in Health & Disease, 2014, v. 13, p. 1
- By:
- Publication type:
- Article
Effect of simvastatin on castration-resistant prostate cancer cells.
- Published in:
- Lipids in Health & Disease, 2014, v. 13, n. 1, p. 56, doi. 10.1186/1476-511X-13-56
- By:
- Publication type:
- Article
Efficacy of an oral and tropically stable lipid-based formulation of Amphotericin B (iCo-010) in an experimental mouse model of systemic candidiasis.
- Published in:
- Lipids in Health & Disease, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1476-511X-12-158
- By:
- Publication type:
- Article
Dietary supplementation with phytosterol and ascorbic acid reduces body mass accumulation and alters food transit time in a diet-induced obesity mouse model.
- Published in:
- Lipids in Health & Disease, 2011, v. 10, n. 1, p. 107, doi. 10.1186/1476-511X-10-107
- By:
- Publication type:
- Article
Effect of dietary fat on hepatic liver X receptor expression in P-glycoprotein deficient mice: implications for cholesterol metabolism.
- Published in:
- Lipids in Health & Disease, 2008, v. 7, p. 1, doi. 10.1186/1476-511X-7-21
- By:
- Publication type:
- Article
Lipid-lowering Activity of Natural and Semi-Synthetic Sterols and Stanols.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Knockdown of scavenger receptor Class B Type I reduces prostate specific antigen secretion and viability of prostate cancer cells.
- Published in:
- Prostate, 2012, v. 72, n. 9, p. 955, doi. 10.1002/pros.21499
- By:
- Publication type:
- Article
Alterations in cholesterol regulation contribute to the production of intratumoral androgens during progression to castration-resistant prostate cancer in a mouse xenograft model.
- Published in:
- Prostate, 2010, v. 70, n. 4, p. 390, doi. 10.1002/pros.21072
- By:
- Publication type:
- Article
Arachidonic acid activation of intratumoral steroid synthesis during prostate cancer progression to castration resistance.
- Published in:
- Prostate, 2010, v. 70, n. 3, p. 239, doi. 10.1002/pros.21057
- By:
- Publication type:
- Article
Androgen-mediated cholesterol metabolism in LNCaP and PC-3 cell lines is regulated through two different isoforms of acyl-coenzyme A: Cholesterol Acyltransferase (ACAT).
- Published in:
- Prostate, 2008, v. 68, n. 1, p. 20, doi. 10.1002/pros.20674
- By:
- Publication type:
- Article
Influence of lovastatin on the pharmacokinetics, toxicity and immunologic response of cyclosporine in the obese zucker rat.
- Published in:
- Biopharmaceutics & Drug Disposition, 1990, v. 11, n. 3, p. 197, doi. 10.1002/bdd.2510110304
- By:
- Publication type:
- Article
A Novel Tropically Stable Oral Amphotericin B Formulation (iCo-010) Exhibits Efficacy against Visceral Leishmaniasis in a Murine Model.
- Published in:
- PLoS Neglected Tropical Diseases, 2010, v. 4, n. 12, p. 1, doi. 10.1371/journal.pntd.0000913
- By:
- Publication type:
- Article
A Novel Tropically Stable Oral Amphotericin B Formulation (iCo-010) Exhibits Efficacy against Visceral Leishmaniasis in a Murine Model.
- Published in:
- PLoS Neglected Tropical Diseases, 2010, v. 4, n. 12, p. 1, doi. 10.1371/journal.pntd.0000913
- By:
- Publication type:
- Article
Effects of climate change on soil health resulting in an increased global spread of neglected tropical diseases.
- Published in:
- PLoS Neglected Tropical Diseases, 2023, v. 16, n. 6, p. 1, doi. 10.1371/journal.pntd.0011378
- By:
- Publication type:
- Article
Enhanced Amphotericin B Nephrotoxicity in Intensive Care Patients with Elevated Levels of Low-Density Lipoprotein Cholesterol.
- Published in:
- Clinical Infectious Diseases, 1997, v. 24, n. 1, p. 78
- By:
- Publication type:
- Article
Characteristics of Lipid-Based Formulations That Influence Their Biological Behavior in the Plasma of Patients.
- Published in:
- Clinical Infectious Diseases, 1996, v. 23, n. 5, p. 1126
- By:
- Publication type:
- Article
Which New Approaches to Tackling Neglected Tropical Diseases Show Promise?
- Published in:
- PLoS Medicine, 2010, v. 7, n. 5, p. 1, doi. 10.1371/journal.pmed.1000255
- By:
- Publication type:
- Article
Safety, pharmacokinetics and pharmacodynamics of four-hour intravenous infusions of eritoran in healthy Japanese and Caucasian men.
- Published in:
- Innate Immunity, 2012, v. 18, n. 6, p. 793, doi. 10.1177/1753425912441845
- By:
- Publication type:
- Article
Deactivation of the lipopolysaccharide antagonist eritoran (E5564) by high-density lipoprotein-associated apolipoproteins.
- Published in:
- Innate Immunity, 2012, v. 18, n. 1, p. 171, doi. 10.1177/1753425910394395
- By:
- Publication type:
- Article